Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Core EBITDA Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 12.5759.64-14.83-17.6213.02

What is the latest Core EBITDA Growth ratio of AUROBINDO PHARMA ?

The latest Core EBITDA Growth ratio of AUROBINDO PHARMA is 12.57 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202512.57
Mar202459.64
Mar2023-14.83
Mar2022-17.62
Mar202113.02

How is Core EBITDA Growth of AUROBINDO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 12.57
-78.92
Mar2024 59.64
Positive
Mar2023 -14.83
Negative
Mar2022 -17.62
Negative
Mar2021 13.02 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Core EBITDA Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹60,115.7 Cr -2.3% -10.5% -34.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹378,999.0 Cr -2.2% -8.3% -13.1% Stock Analytics
DIVIS LABORATORIES ₹163,635.0 Cr -1.1% -7.3% 21.6% Stock Analytics
CIPLA ₹127,544.0 Cr -0.7% 1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,050.0 Cr -0.5% -4.2% 4.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,373.0 Cr -0.5% -1.1% -7.7% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.3%

-10.5%

-34.4%

SENSEX

-0.3%

-0.8%

-1.9%


You may also like the below Video Courses